Cinnarizine
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171807This classification denotes a histamine-1 receptor antagonist with the molecular formula C26H28N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DI2E1X18L, chemically known as piperazine, 1- (diphenylmethyl)-4-(3-phenyl-2-propenyl)-, (e)- but generally known as cinnarizine, which bears US NIH Compound Identifier 2761. European Medicines Agency schedules Cinnarizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06302MIG. The term CINNARIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules cinnarizine in its Anatomical Therapeutic Chemical (ATC) Classification. CINNARIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinnarizine under HS 29335995 and SITC 51576. As of Q4 2014, CINNARIZINE remains the US FDA Preferred Term for this commodity. Cinnarizine bears US NLM identifiers UMLS ID C0008803 and NCI Concept Code C76060. SMILES: N1(CCN(CC1)C/C=C/C1CCCCC1)C(C1CCCCC1)C1CCCCC1.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.